Skip Navigation

European Heart Journal 2001 22(13):1067-1069; doi:10.1053/euhj.2000.2573
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McFadden, E.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFadden, E.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Fibrinolysis and stenting in acute myocardial infarction: newlyweds destined for a ‘ménage à trois’?

E.P. McFadden

Hôpital Cardiovasculaire et Pneumologique, Louis Pradel, Lyon, France

References

  1. N Engl J Med. 1993;329:1615–1622[Abstract/Free Full Text]
  2. Meijer A, Verheugt FWA, Werter CJPJ, Lie KI, van der Pol JMJ, van Eenige MJ. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled study. Result of the APRICOT study. Circulation. 1993;87:1524–1530[Abstract/Free Full Text]
  3. JAMA. 1998;260:2849–2858
  4. Simoons ML, Arnold AE, Betriu A. Thrombolysis with t-PA in acute myocardial infarction; no benefit of immediate PTCA. Lancet. 1988;I:197–203
  5. Lancet. 1988;II:349–360
  6. Franzosi MG, Santoro E, DeVita C. Ten year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Results of GISSI-1 study. Circulation. 1998;98:2659–2665[Abstract/Free Full Text]
  7. Ito H, Tomooka T, Sakai N. Lack of myocardial perfusion immediately after successful thrombolysis. Circulation. 1992;85:1699–1705[Abstract/Free Full Text]
  8. Nunn CM, O'Neill WW, Rothbaum D. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-1) trial. J Am Coll Cardiol. 1999;33:1729–1736
  9. Maillard L, Hamon M, Khalife K. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2000;35:1729–1736[Abstract/Free Full Text]
  10. Grines CL, Cox DA, Stone GW. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Group. N Engl J Med. 1999;341:1949–1956[Abstract/Free Full Text]
  11. Loubeyre C, Lefèvre T, Louvard Y. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J. 2001;22:1128–1135[Abstract/Free Full Text]
  12. Zahn R, Schiele R, Schneider S. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol. 2000;36:2064–2071[Abstract/Free Full Text]
  13. Antman EM, Giugliano RP, Gibson CM. Abciximab facilitates the rate and extent of thrombolysis: Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial. Circulation. 1999;99:2720–2732[Abstract/Free Full Text]
  14. Antman EM, Gibson CM, De Lemos JA. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. Eur Heart J. 2000;21:1944–1953[Abstract/Free Full Text]
  15. Herrmann HC, Moliterno DJ, Ohman EM. Facilitation of early percutaneous intervention after reteplase with or without abciximab in acute myocardial infarction. Results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol. 2000;36:1489–1496[Abstract/Free Full Text]
  16. Armstrong PW. Reperfusion synergism: will it be both sustained and safe? [Editorial]. Eur Heart J. 2000;21:1913–1916[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McFadden, E.P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFadden, E.P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?